TLDR:
- Israeli VC fund Kidron Capital Assets dedicated to women’s health completes first close
- Investing in companies focusing on improving women’s health conditions
An Israeli venture capital fund dedicated to women’s health, Kidron Capital Assets, has announced the successful completion of its first close, allowing the fund to begin investing in projects. Led by women, the fund aims to generate solid returns for its investors by focusing on opportunities in the often-overlooked women’s health sector. Kidron invests in early-stage companies that address a variety of women’s health conditions, including those unique to women and those that manifest differently in the two sexes.
The fund’s investment portfolio includes companies in medical devices, diagnostics, and therapeutics, with investments in Europe, Israel, and the US. Some of Kidron’s inaugural investments include Beyond Medicine, targeting mitochondria to improve health as people age and ease menopausal symptoms; Portal, providing scalable solutions for oncology clinics treating women with cancer; and Renal Guard, offering a solution for Acute Kidney Injury (AKI) with a heightened risk for women undergoing cardiac surgery.
Kidron Capital Assets is dedicated to supporting innovation in women’s health and aims to make a meaningful impact in improving the lives of women worldwide through its investments.
